Mariam Ileyemi, an investigative health and development reporter with PREMIUM TIMES, has secured a coveted spot among the final three nominees for the Outstanding Health Investigation Award ahead of the 2026 Private Sector Health Alliance of Nigeria (PSHAN) Annual Awards. The announcement, made public on Monday, places her work firmly in the spotlight within the Media and Innovative Health Communication category, recognizing rigorous reporting that exposes deep-seated systemic vulnerabilities within Nigeria’s healthcare landscape.
Her nomination stems from an extensive, data-driven open-source investigation titled “Social media, anonymous websites drive Nigeria’s poorly regulated weight-loss injection market.” The piece offered a searing exposé on how potent weight-loss injections are aggressively marketed, sold, and administered across the country completely free of medical prescriptions or regulatory oversight. Furthermore, the report revealed a complex digital web of anonymous e-commerce platforms and social media channels pushing experimental weight-loss substances, including retatrutide—an investigational pharmaceutical product that remains restricted to ongoing clinical trials and has not received final regulatory authorization for public consumption.
The annual PSHAN awards scheme is designed to celebrate excellence, innovation, and unwavering dedication toward transforming the nation’s health sector through collaborative private-public intervention. According to organizers, the Outstanding Health Investigation category specifically honors media practitioners whose deep investigative rigor unmasks systemic healthcare failures, public safety hazards, and regulatory lapses.
A Competitive Field of Investigative and Digital Heavyweights
In the race for the Outstanding Health Investigation Award, Ms. Ileyemi shares the spotlight with other formidable journalistic voices. She is nominated alongside Sadeeq Atanda of the Foundation for Investigative Journalism (FIJ), as well as the collaborative investigative team of Yemisi Adegoke, Chigozie Nwonwu, and Lina Shaikhouni representing the British Broadcasting Corporation (BBC/BBC Eye).
The competitive landscape extends across multiple categories designed to honor digital health communication, advocacy, and traditional reporting. In the Health Influencer of the Year category—which acknowledges digital content creators who effectively leverage online platforms to promote credible medical awareness—the top three nominees include Olawale Ogunlana, Olufunke Arowolo, and Chinonso Egemba, widely known by his popular moniker, Aproko Doctor.
Meanwhile, the Health Journalism Excellence Award finalists highlight the relentless daily reporting of veteran journalists within the print, broadcast, and new media sectors. Nominees in this category feature Racheal Abujah of the News Agency of Nigeria (NAN), Ojoma Akor of Health & Science Africa, and Bilkis Abdulraheem-Lawal of Radio Nigeria/Grassroots Broadcast.
Organizers have confirmed that an independent expert panel of judges, comprising seasoned healthcare professionals, public health experts, and media veterans, will review the finalists. The ultimate winners across all categories will be officially unveiled and decorated during the high-profile PSHAN Annual Awards and Gala Night, scheduled for 20 November 2026.
Anatomy of an Investigation: Unregulated Weight-Loss Drugs in Nigeria
The investigation that earned Ms. Ileyemi her national nomination addresses a growing public health emergency characterized by the unchecked commercialization of lifestyle and anti-obesity medications. In recent years, the global surge in demand for peptide-based and incretin-mimetics weight-loss therapies has triggered a massive parallel market in developing nations, particularly in urban centers across Nigeria.
Through meticulous digital forensics, open-source intelligence gathering, and undercover tracking, the PREMIUM TIMES report demonstrated how easy it is for ordinary citizens to procure powerful medications via Instagram, TikTok, Facebook, and dedicated e-commerce web portals. Sellers routinely bypassed foundational medical protocols, failing to request baseline metabolic panels, kidney function tests, or physician consultations. Most alarmingly, the investigation tracked the distribution of retatrutide—a novel triple-hormone receptor agonist currently undergoing advanced clinical trials globally. The availability of an experimental drug on unregulated Nigerian digital marketplaces underscores critical enforcement gaps within the National Agency for Food and Drug Administration and Control (NAFDAC) and related regulatory bodies.
Public health analysts have repeatedly warned that the consumption of prescription-only drugs without clinical supervision can lead to severe adverse physiological outcomes, including acute pancreatitis, gallbladder disease, severe gastrointestinal complications, thyroid C-cell tumors, and life-threatening hypoglycemic episodes. By shedding light on these digital black markets, Ms. Ileyemi’s work has reignited urgent conversations regarding the intersection of social media governance, cross-border pharmaceutical smuggling, and consumer safety protection in Nigeria.
Background and Professional Accolades of Mariam Ileyemi
The latest PSHAN nomination adds to a rapidly expanding portfolio of professional honors and recognitions earned by Ms. Ileyemi. Operating from the Health and Development Desk at PREMIUM TIMES, she has built a reputation for impactful journalism that bridges complex scientific data with human-interest narratives, covering critical beats spanning public health, gender equality, and international development.
Her dedication to journalistic excellence was underscored in late 2025 when she was named the PREMIUM TIMES Reporter of the Year during the media organization’s Annual Editorial Awards. Her investigative and explanatory reporting has also earned her competitive fellowships and academic recognitions across the African continent. She is an alumnus of the prestigious 2025 Africa Health Communications Fellowship administered by Fraycollege in South Africa and a beneficiary of the 2023 Media-EIS Fellowship.
Additionally, Ms. Ileyemi is a proud recipient of the Mamman Marshall Scholarship for Women in Journalism, a distinction that recognizes tenacity and promise among female media practitioners in Nigeria. In 2024, her impactful reporting also earned her a nomination for the Nigeria Healthcare Excellence Award under the Prevent Epidemics category, cementing her status as one of the country’s leading young investigative health reporters. A graduate of Lagos State University (LASU), where she earned her Bachelor of Science degree in Mass Communication, she continues to utilize data-driven storytelling to hold institutions accountable and advocate for structural reforms in the health sector.
Broader Implications and Industry Reactions
The recognition of investigative journalists by bodies like PSHAN highlights a vital paradigm shift in how private sector stakeholders view the media—not merely as chroniclers of events, but as essential partners in national development and public safety. PSHAN, a leading private-sector-led platform that collaborates with government entities to strengthen Nigeria’s healthcare delivery systems, has consistently emphasized that systemic health challenges require multi-sectoral solutions.
Industry observers note that recognizing rigorous health journalism helps direct executive attention and regulatory willpower toward gray areas that might otherwise escape formal oversight. As digital platforms continue to evolve faster than statutory regulatory frameworks, investigative reporting serves as an early-warning system for policymakers, consumer protection agencies, and medical associations.
As the countdown to the November 20, 2026, gala night begins, the nomination of Mariam Ileyemi stands as a testament to the enduring power of investigative journalism to provoke public discourse, safeguard vulnerable populations, and drive meaningful policy reform within Nigeria’s dynamic healthcare ecosystem.
